DPI-3290 (Serbian Wikipedia)
Analysis of information sources in references of the Wikipedia article "DPI-3290" in Serbian language version.
refsWebsite
Global rank
Serbian rank
11th place
23rd place
doi.org (Global: 2nd place; Serbian: 4th place)
- Gengo, PJ; Pettit, HO; O'Neill, SJ; Wei, K; McNutt, R; Bishop, MJ; Chang, KJ (2003). „DPI-3290 (+)-3-((alpha-R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide. I. A mixed opioid agonist with potent antinociceptive activity”. The Journal of Pharmacology and Experimental Therapeutics. 307 (3): 1221—6. PMID 14534368. S2CID 93569860. doi:10.1124/jpet.103.054361.
- Gengo, PJ; Pettit, HO; O'Neill, SJ; Su, YF; McNutt, R; Chang, KJ (2003). „DPI-3290 (+)-3-((alpha-R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide. II. A mixed opioid agonist with potent antinociceptive activity and limited effects on respiratory function”. The Journal of Pharmacology and Experimental Therapeutics. 307 (3): 1227—33. PMID 14534367. S2CID 45159720. doi:10.1124/jpet.103.054429.
- Ananthan, S. (2006). „Opioid ligands with mixed mu/Delta opioid receptor interactions: An emerging approach to novel analgesics”. The AAPS Journal. 16584118 (1): E118—25. PMC 2751430
. PMID 16584118. doi:10.1208/aapsj080114.
nih.gov (Global: 4th place; Serbian: 8th place)
ncbi.nlm.nih.gov
- Gengo, PJ; Pettit, HO; O'Neill, SJ; Wei, K; McNutt, R; Bishop, MJ; Chang, KJ (2003). „DPI-3290 (+)-3-((alpha-R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide. I. A mixed opioid agonist with potent antinociceptive activity”. The Journal of Pharmacology and Experimental Therapeutics. 307 (3): 1221—6. PMID 14534368. S2CID 93569860. doi:10.1124/jpet.103.054361.
- Gengo, PJ; Pettit, HO; O'Neill, SJ; Su, YF; McNutt, R; Chang, KJ (2003). „DPI-3290 (+)-3-((alpha-R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide. II. A mixed opioid agonist with potent antinociceptive activity and limited effects on respiratory function”. The Journal of Pharmacology and Experimental Therapeutics. 307 (3): 1227—33. PMID 14534367. S2CID 45159720. doi:10.1124/jpet.103.054429.
- Ananthan, S. (2006). „Opioid ligands with mixed mu/Delta opioid receptor interactions: An emerging approach to novel analgesics”. The AAPS Journal. 16584118 (1): E118—25. PMC 2751430 . PMID 16584118. doi:10.1208/aapsj080114.
semanticscholar.org (Global: 11th place; Serbian: 23rd place)
api.semanticscholar.org
- Gengo, PJ; Pettit, HO; O'Neill, SJ; Wei, K; McNutt, R; Bishop, MJ; Chang, KJ (2003). „DPI-3290 (+)-3-((alpha-R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide. I. A mixed opioid agonist with potent antinociceptive activity”. The Journal of Pharmacology and Experimental Therapeutics. 307 (3): 1221—6. PMID 14534368. S2CID 93569860. doi:10.1124/jpet.103.054361.
- Gengo, PJ; Pettit, HO; O'Neill, SJ; Su, YF; McNutt, R; Chang, KJ (2003). „DPI-3290 (+)-3-((alpha-R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide. II. A mixed opioid agonist with potent antinociceptive activity and limited effects on respiratory function”. The Journal of Pharmacology and Experimental Therapeutics. 307 (3): 1227—33. PMID 14534367. S2CID 45159720. doi:10.1124/jpet.103.054429.